Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: snerd who wrote (5151)	1/19/1999 2:53:00 PM
From: campe	Respond to of 56532

ASTM (Related) - Here's the full release... I'm reading ASTM and GERN between the lines. Tuesday January 19, 1:23 pm Eastern Time Company Press Release SOURCE: Alliance for Aging Research Clinton Administration Stem Cell Decision Called 'Important and Historic' by Alliance WASHINGTON, Jan. 19 /PRNewswire/ -- An Administration statement that human embryonic stem cells do not fall under the current federal ban on embryo research was hailed as ''important and historic,'' by Alliance for Aging Research Executive Director Daniel Perry today in testimony before the National Bioethics Advisory Commission. Appearing before the NBAC earlier, National Institutes of Health Director Harold Varmus stated that the Clinton Administration believes the NIH has the authority to fund research using laboratory cultures of human stem cells in accordance with current law. Since November, when it was first reported that scientists have derived long-lived human cells that maintain the potential to be turned into any cell in the body, the research community has awaited a decision regarding NIH support for such research. For the past three years, Congressional appropriating committees have prohibited research that could risk injury or harm to human embryos. Concerns have been raised that the federal ban could be interpreted to apply to stem cells which are derived from early-stage embryos donated as a consequence of in vitro fertilization. That could have the effect of shutting out NIH and many academic researchers from studying highly promising new cell lines. ''It is vitally important that the view expressed by Dr. Varmus today should prevail in federal policy,'' Perry told the bioethics commission. ''If that view does prevail, it is likely many of the best prepared and best equipped research scientists in the nation will move quickly to begin revealing new insights into human cell biology, made possible by one of the most important discoveries of our time,'' he said. Human stem cells can be maintained indefinitely in laboratory conditions in an undifferentiated state. They have the potential to be turned into young cells that could function in any part of the body. Heart disease, Parkinsons, cancer, diabetes and cancer are among the diseases of aging that could possibly be treated in the future with products of stem cell technology. ''The potential therapeutic impact of human embryonic stem cells in replacing cells and tissues damaged by disease or aging is enormous,'' Perry said. The Alliance for Aging Research is a not-for-profit organization that promotes scientific and medical research to improve the health and independence of growing number of older Americans. *** Daniel Perry is available for interview by calling the contact below. CONTACT: Jeffrey Bukowski of the Alliance for Aging Research, 202-293-2856. SOURCE: Alliance for Aging Research biz.yahoo.com